Oramed Pharmaceuticals is a research and development company focused on creating pharmaceutical solutions for diabetes treatment. They specialize in developing orally ingestible capsules or pills for delivering polypeptides. Their product portfolio includes insulin capsules for type 2 diabetes and non-alcoholic steatohepatitis, as well as a glucagon-like peptide-1 capsule for type 2 diabetes. The company was founded in 2002 and is based in New York.